← Back to Search

Corticosteroid

Steroid Therapy for Distal Radius Fracture

Phase 1
Waitlist Available
Research Sponsored by Indiana Hand to Shoulder Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial compares outcomes, pain control, and recovery of wrist fracture patients who receive steroids in surgery to those who don't - 18 patients in each group will be tracked for 6 months.

Eligible Conditions
  • Distal Radius Fracture
  • Broken Bones
  • Fractures

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Range of Motion
Secondary outcome measures
Visual Analogue Scale (VAS) Pain
Other outcome measures
Return to Work

Trial Design

2Treatment groups
Experimental Treatment
Group I: Test GroupExperimental Treatment2 Interventions
Test Group will receive 10mg intravenous dexamethasone at the time of incision, administered by the assigned anesthesiologist. Post-surgery, Test Group patients will be prescribed a 6-day oral methylprednisolone taper course.
Group II: Control GroupExperimental Treatment1 Intervention
Standard of care with no placebo
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dexamethasone
2007
Completed Phase 4
~2590
Methylprednisolone
2015
Completed Phase 4
~2280

Find a Location

Who is running the clinical trial?

Indiana Hand to Shoulder CenterLead Sponsor
8 Previous Clinical Trials
320 Total Patients Enrolled

Media Library

Dexamethasone (Corticosteroid) Clinical Trial Eligibility Overview. Trial Name: NCT05655130 — Phase 1
Distal Radius Fracture Research Study Groups: Test Group, Control Group
Distal Radius Fracture Clinical Trial 2023: Dexamethasone Highlights & Side Effects. Trial Name: NCT05655130 — Phase 1
Dexamethasone (Corticosteroid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05655130 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Test Group's product line compliant with FDA standards?

"Due to the fact that this is a Phase 1 trial, with limited data available on safety and efficacy, our team at Power has rated Test Group's safety as a one."

Answered by AI

Are there any current openings for this research project?

"Contrary to the information on clinicaltrials.gov, this trial does not presently have openings for participants and no updates were made after December 14th 2022. Although, there are still 358 other trials currently recruiting patients."

Answered by AI
~5 spots leftby Apr 2025